Name | YXG-158 |
---|
Description | YXG-158 (Compound 23-h) is an orally active AR degrader and CYP17A1 inhibitor. YXG-158 has AR degradation activity with DC50 value of 1.28 μM. YXG-158 can inhibit CYP17A1 with IC50 value of 100 nM. XG-158 can be used for the research of enzalutamide-resistant prostate cancer[1]. |
---|---|
Related Catalog | |
Target |
DC50: 1.28 μM (androgen receptor)[1]. IC50: 100 nM (CYP17A1)[1]. |
References |
Molecular Formula | C30H36FN3O |
---|---|
Molecular Weight | 473.62 |